BAC vs PVLA Stock Comparison

PVLA currently leads BAC in this stock comparison, with AIQ scores of 70 vs 58. The clearest difference is momentum, while BAC has the stronger risk resilience profile.

Market data as of Nov 15, 2026 market close· AIQ score gap 12 points
BAC
Financial Services
vs
PVLA
Healthcare
BAC
Bank of America Corporation
Price
$51.02
Day move
+1.01%
AIQ Score
58/100
Best edge
Risk Resilience
Sector
Financial Services
PVLA
Palvella Therapeutics, Inc.
Leads
Price
$152
Day move
-0.46%
AIQ Score
70/100
Best edge
Momentum
Sector
Healthcare

What is the main difference between BAC and PVLA?

PVLA leads the current stock comparison as Palvella Therapeutics, Inc., with the clearest separation coming from momentum and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Bank of America Corporation vs Palvella Therapeutics, Inc.

Data as of Nov 15, 2026· market close· Cross-sector · Financial Services vs Healthcare· Coverage 64/66 fields· High confidence
AIQ VerdictCompetitiveAIQ Comparison Conviction 6/10

PVLA leads

PVLA leads by 12 AIQ points, primarily on Momentum, having only recently taken the lead back from BAC.

Competitive: 3 of 5 evidence groups support PVLA, the lead recently changed hands, and its signal state is cleanly positive.

Evidence agreement: 3 of 5Comparison trend: Reversed
BAC

Bank of America Corporation

AIQ Score
58/100
AIQ Edge Score
6/10
PVLA

Palvella Therapeutics, Inc.

Leads
AIQ Score
70/100
AIQ Edge Score
10/10

The Algovestiq AIQ Score currently favors PVLA over BAC, 70 versus 58 as of Nov 15, 2026. PVLA's advantage is driven primarily by stronger momentum, while BAC holds the stronger risk resilience profile. PVLA also shows the stronger technical structure relative to its 50-day moving average. 3 of 5 covered evidence groups favor PVLA today, and the comparison is rated Competitive on stability: the lead has already changed hands inside the comparison window. PVLA lead: Reversed — BAC led by 1 AIQ points 30 sessions ago; PVLA now leads by 12.

Compare Bank of America Corporation and Palvella Therapeutics, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

BAC
+16.6%
PVLA
+1088.5%

Total return comparison

Growth of $10,000, distributions reinvested

BAC $11,665 · PVLA $118,846

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare BAC and PVLA against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

BAC advantage
0
PVLA advantage
  • Momentum37 vs 84
    PVLA +47
  • Risk Resilience83 vs 47
    BAC +36
  • Quality64 vs 65
    Even

3 of 5 evidence groups favor PVLA. PVLA’s edge is concentrated in momentum; BAC keeps a meaningful risk resilience edge.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

BAC0 AIQ

No factor moved materially.

New signals

  • OBV Bullish Divergence — bullish, volume, medium horizon (-0.4%)
PVLA+2 AIQ

Largest factor move: Momentum +4

No signal started or stopped since the prior session; its 5 active signals are unchanged.

PVLA's lead widened by 2 AIQ points in the latest session.

Deeper signal detail for each name lives on its own signals page — BAC and PVLA both carry a full feed there.

The central trade-off

PVLA (Palvella Therapeutics, Inc.): the stronger current systematic profile, led by momentum.

BAC (Bank of America Corporation): the counter-case, on risk resilience.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

PVLA

PVLA on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

PVLA

PVLA on combined revenue and EPS growth.

Value

Even

The two are level on Value.

Momentum

PVLA

PVLA on the Momentum factor, by 47 points.

Lower downside

BAC

BAC on Risk Resilience, by 36 points.

Analyst upside

PVLA

PVLA on implied upside to the consensus price target.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureBACPVLANote
Implied upside to target+24.1%+55.6%PVLA has more room
Target dispersion+25.3%+8.4%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering2516Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

3 of 5 covered evidence groups favor PVLA. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScorePVLA58 vs 70
FundamentalsEvenEPS growth -23.8% vs -11.8%; TTM ROE 2.3% vs -12.5%
ValuationNot coveredNot covered
TechnicalsPVLAPrice vs 50-day -5.6% vs 6.2%; vs 200-day -7% vs 16.9%
Risk ResilienceBACRisk Resilience 83 vs 47
Analyst expectationsPVLATarget upside 24.1% vs 55.6%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of BAC and PVLA and are excluded from the count.

AIQ Decision Stability

Competitive

The two are close enough that your objective, not the score, should decide.

  • The AIQ gap is wide at 12 points. (supports the conclusion holding)
  • The lead has already changed hands inside the comparison window. (argues the conclusion is provisional)
  • The leader's signal state is cleanly positive. (supports the conclusion holding)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on PVLA.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

PVLA lead: Reversed — BAC led by 1 AIQ points 30 sessions ago; PVLA now leads by 12.

May 27BAC leads above the line · PVLA leads belowNov 13
Today
PVLA +12
58 vs 70
7 sessions ago
PVLA +9
58 vs 67
30 sessions ago
BAC +1
62 vs 61
90 sessions ago
Level
71 vs 71

The lead changed hands 8 times in this window, most recently on Oct 22 when PVLA moved ahead of BAC.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

BACConflicted

2 bullish / 2 bearish / 1 neutral, conflicted

Only BAC

  • Bollinger Band Squeeze — neutral, volatility, short horizon (4.5%)
  • Death Cross Active — bearish, trend, long horizon (1.45%)
  • Downtrend Structure Active — bearish, trend, long horizon
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon
  • OBV Bullish Divergence — bullish, volume, medium horizon (-0.4%)
PVLA

4 bullish / 0 bearish / 1 neutral

Only PVLA

  • Golden Cross Active — bullish, trend, long horizon (10.05%)
  • ATR Expansion - Breakout Mode — neutral, volatility, short horizon (6.32%)
  • EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
  • TRIX Bullish Signal — bullish, momentum, short horizon
  • Uptrend Structure Active — bullish, trend, long horizon

BAC is conflicted, so the timing case there is weaker than the score alone suggests.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

BACNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +1.01%, AIQ 0 points).

PVLADivergence

Price is down while the AIQ Score moved up 2 points over the same session — price and model disagree (price -0.46%, AIQ +2 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1BAC closes the Momentum gap — currently 47 points behind, the largest single contributor to PVLA's edge.
  2. 2BAC's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3PVLA's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

Split
MetricBACPVLA
Revenue growth (YoY)-3.3%0%
EPS growth (YoY)-23.8%-11.8%
Gross margin60.4%0%
Operating margin22.4%0%
Return on equity (TTM)2.3%-12.5%
Debt to equity1.280

Performance

PVLA leads 5 of 6 windows
MetricBACPVLA
1 week (5 sessions)3.2%-13.3%
1 month (20 sessions)-0.4%26.7%
3 months (63 sessions)-20.1%-0.7%
6 months (126 sessions)2.5%33.5%
Year to date-7.2%45.7%
1 year (252 sessions)-5.7%87%

Technicals

PVLA has the stronger structure
MetricBACPVLA
RSI (14)45.952.6
ADX (14)27.231.1
Price vs 50-day-5.6%6.2%
Price vs 200-day-7%16.9%
Volatility (1M, annualized)24.8%75.1%

Risk

BAC is the more resilient
MetricBACPVLA
Beta0.791.65
Sharpe ratio-0.221.12
Sortino ratio-0.291.87
Max drawdown-23.7%-31.1%
Current drawdown-21.3%-13.3%
Annualized volatility22.4%84.5%
Value at risk (95%)-2.6%-6.9%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, BAC or PVLA?

On the Algovestiq AIQ Score, PVLA is the stronger of the two as of Nov 15, 2026, scoring 70 against BAC's 58. The edge comes from momentum. BAC is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is BAC or PVLA the better buy right now?

PVLA carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Competitive — 3 of 5 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.

Why does the AIQ Score favor PVLA over BAC?

The composite weights Quality, Value, Momentum and Risk Resilience. PVLA leads Momentum by 47 points; BAC leads Risk Resilience by 36 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, BAC or PVLA?

Analyst price targets imply +24.1% upside for BAC and +55.6% for PVLA, so the Street currently favors PVLA. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, BAC or PVLA?

Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, BAC or PVLA?

PVLA on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, BAC or PVLA?

PVLA on the Momentum factor, by 47 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, BAC or PVLA?

BAC is the more resilient of the two, so the other name carries the higher downside risk. BAC on Risk Resilience, by 36 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is BAC more profitable than PVLA?

BAC leads on the comparable margin measures — gross margin 60.4% vs 0%; operating margin 22.4% vs 0%; ttm roe 2.3% vs -12.5%.

Is PVLA's lead over BAC getting stronger or weaker?

PVLA lead: Reversed — BAC led by 1 AIQ points 30 sessions ago; PVLA now leads by 12. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands 8 times in that window, most recently on 2026-10-22, when PVLA moved ahead of BAC.

What would change the BAC vs PVLA verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: BAC closes the Momentum gap — currently 47 points behind, the largest single contributor to PVLA's edge; BAC's Death Cross Active resolves — a bearish trend rule currently active against it; PVLA's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about BAC and PVLA?

BAC: 2 bullish / 2 bearish / 1 neutral, conflicted. PVLA: 4 bullish / 0 bearish / 1 neutral. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on BAC is Death Cross Active (bearish, long horizon). On PVLA it is Golden Cross Active (bullish, long horizon).

Compare BAC and PVLA with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.